Stock Evaluator: PMGC Holdings Inc. (ELAB)

PMGC Holdings Inc. ELAB

$0.92 -0.03 -2.78%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 210,060
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Consumer Staples Personal Care Products

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company’s lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

Commentary & Analysis


Financial Summary

Share Statistics ELAB Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $4.2 $337.9 3%
Shares Out (Mil) 0.4 27.3 2%
Institutional Ownership 100.0% 55.3% 99%
Float (Mil) 4.1 30.7 10%
Beta -0.28 0.56 3%
Avg Daily Volume (000s) 765 150 66%
Price Change
(52-week)
(99.5%) 56.7% 1%
Growth ELAB Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 2.3% na
Net Income (5yr) (138.4%) (4.8%) 1%
EPS (5yr) na 2.3% na
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) na (13.2%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials ELAB Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $1 $421 2%
Net Income (TTM) (Mil) ($11) $0 28%
EPS (TTM) ($85.530) $0.100 1%
Operating Cash Flow (TTM) (Mil) ($8) $12 21%
Net Cash Flow (TTM) (Mil) $9 $0 57%
Long-Term Debt (Q1) (Mil) $2 $44 20%
Enterprise Value (Q1) (Mil) $1 $334 4%
Valuation ELAB Industry
Median
Percentile
(All Stocks)
P/B 0.14 2.05 2%
P/E na 16.4 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 0.7 na
Ratios ELAB Industry
Median
Percentile
(All Stocks)
Gross Margin (63.1%) 64.3% 2%
Net Margin (873.1%) 1.6% 0%
ROA (63.6%) 1.3% 9%
ROE (107.1%) 5.3% 9%
Liabilities to Assets 51.6% 48.0% 44%
F-Score 2 4 na

PMGC Holdings Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors